Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: WHAT IF THERE'S BAD NEWS? SHOULD THE BOD TELL SHAREHOLDERS?

Usually yes. The shareholders will eventually find out and won't appreciate the BoD trying to hide it.

Share
New Message
Please login to post a reply